Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

Electronic health records (EHRs); insurance claims; patient registries; wearable tech: Never before has health data been so abundant. However, the United States continues to struggle with siloed ...

Venetoclax shows similar efficacy and safety in real-world settings and clinical trials for CLL treatment, with a 94% overall response rate. Real-world studies provide insights into diverse patient ...

Traditionally, AI progress was constrained by one thing above all else: access to data. Not enough volume. Not enough ...

In the late 1800s, the U.S. railroad system didn’t just revolutionize transportation—it catalyzed entirely new industries. Refrigerated railcars enabled a national meatpacking economy. Standard time ...

The data and insights highlighted in the article are drawn from the Biotech Playbook for Progress, a comprehensive resource built from a 2025 TriNetX survey of 150 biotech and pharma executives.

The National Institute on Aging has launched a $27.2 million initiative to create a unified network aimed at accelerating Alzheimer’s and dementia research. The five-year project — titled “Using ...

The European Medicines Agency (EMA) uses Data Analysis and Real-World Interrogation Network (DARWIN EU), a data network that became fully operational in 2024, to generate real-world evidence on ...

Please provide your email address to receive an email when new articles are posted on . Izervay injections for geographic atrophy led to acute IOP increases in 3% of eyes in a real-world dataset ...

Physician-assessed confirmed ORR reached 44% (18/41) with 73% disease control, suggesting robust activity in checkpoint- and targeted-refractory advanced melanoma. Comparative context showed higher ...

New research shows patients commonly take lower doses of nintedanib, and the majority are also taking immunomodulatory drugs. Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev ...